145 related articles for article (PubMed ID: 10744098)
21. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
Bokemeyer C
Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
[TBL] [Abstract][Full Text] [Related]
22. Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.
van den Hengel LG; van Steijn-van Tol AQ; Bertina RM; Versteeg HH; Osanto S
Thromb Res; 2013 Feb; 131(2):187-9. PubMed ID: 23260444
[No Abstract] [Full Text] [Related]
23. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
[TBL] [Abstract][Full Text] [Related]
24. [Long-term course of blood lipids and body mass index in patients with testicular cancer treated with chemotherapy].
Fernández-Miranda C; Schoebel N; Angulo A; Paz-Ares L; Lianes P; del Palacio A
Rev Clin Esp; 1997 Jul; 197(7):490-3. PubMed ID: 9411545
[TBL] [Abstract][Full Text] [Related]
25. Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.
Altena R; Fehrmann RS; Boer H; de Vries EG; Meijer C; Gietema JA
PLoS One; 2015; 10(1):e0115372. PubMed ID: 25590623
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of plasma platinum in a hemodialysis patient receiving repeated doses of cisplatin.
Hirai K; Ishiko O; Sumi T; Kanaoka Y; Ogita S
Oncol Rep; 2000; 7(6):1243-5. PubMed ID: 11032923
[TBL] [Abstract][Full Text] [Related]
27. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
Biró K
Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
[TBL] [Abstract][Full Text] [Related]
28. Endocrinological late effects after chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schuppert F; Schmoll HJ
Br J Cancer; 1996 May; 73(9):1108-14. PubMed ID: 8624272
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
Guchelaar HJ; Hoekstra HJ; de Vries EG; Uges DR; Oosterhuis JW; Schraffordt Koops H
Br J Cancer; 1992 Jun; 65(6):898-902. PubMed ID: 1319729
[No Abstract] [Full Text] [Related]
30. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
Fracasso ME; Apostoli P; Benoni G; Bonetti A; Griso C; Leone R
Drugs Exp Clin Res; 1987; 13(6):367-72. PubMed ID: 3652926
[TBL] [Abstract][Full Text] [Related]
31. Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.
Koster R; van Vugt MA; Timmer-Bosscha H; Gietema JA; de Jong S
Expert Rev Mol Med; 2013 Sep; 15():e12. PubMed ID: 24074238
[TBL] [Abstract][Full Text] [Related]
32. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Burgerhof JG; Hoekstra HJ; Sluiter WJ; Gietema JA
Eur J Cancer; 2004 Mar; 40(5):701-6. PubMed ID: 15010071
[TBL] [Abstract][Full Text] [Related]
33. Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer.
Schilsky RL; Barlock A; Ozols RF
Cancer Treat Rep; 1982 Sep; 66(9):1767-9. PubMed ID: 6889461
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy of disseminated seminoma.
Einhorn LH; Williams SD
Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
[TBL] [Abstract][Full Text] [Related]
36. Treatment of testicular cancer: a new and improved model.
Einhorn LH
J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
[TBL] [Abstract][Full Text] [Related]
37. Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated with Platinum-Based Regimens.
Sattar A; Masood M; Nisar H; Fatima I; Shahid AB
J Coll Physicians Surg Pak; 2018 Apr; 28(4):292-296. PubMed ID: 29615170
[TBL] [Abstract][Full Text] [Related]
38. [cis-Diamino-dichloro-platinum (II) in the treatment of otherwise treatment-resistant malignant testicular teratoma (author's transl)].
Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1976 Feb; 101(6):191-5, 199. PubMed ID: 1248396
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of combination chemotherapy including Platidiam in the treatment of malignant testicular tumors.
Garin AM; Lichinitser MR; Khlebnov AV; Tyulyandin SA
Neoplasma; 1987; 34(1):85-8. PubMed ID: 2436066
[TBL] [Abstract][Full Text] [Related]
40. Treatment of "good risk" metastatic testicular cancer.
Garrow GC; Johnson DH
Semin Oncol; 1992 Apr; 19(2):159-65. PubMed ID: 1372758
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]